Recombinant Human Kallikrein 5 Protein: Research Guide
Recombinant Human Kallikrein 5 Protein: Research Guide
Recombinant Human Kallikrein 5 Protein is a trypsin-like serine protease critically involved in epidermal desquamation and skin barrier homeostasis, making it a valuable research tool for studying skin disorders, protease signaling cascades, and related therapeutic targets.
- Protein Name
- Recombinant Human Kallikrein 5 (KLK5)
- Protein Family
- Kallikrein-related peptidase (serine protease) family
- Primary Function
- Trypsin-like serine protease; mediates epidermal desquamation and extracellular matrix remodeling
- Key Research Applications
- Skin barrier studies, protease substrate profiling, Netherton syndrome modeling, biomarker research
- Expression System
- Recombinant expression system (specific host system to be confirmed with product datasheet)
- Related SKU
- rp368170
Biological Background and Function of KLK5
Kallikrein 5 (KLK5), also known as kallikrein-related peptidase 5 or stratum corneum tryptic enzyme (SCTE), is a secreted serine protease belonging to the kallikrein-related peptidase (KLK) family, which comprises 15 members (KLK1–KLK15) encoded in a gene cluster on chromosome 19q13.4 in humans.
KLK5 exhibits trypsin-like activity, cleaving peptide bonds preferentially at the C-terminal side of arginine and lysine residues. Within the epidermis, KLK5 is expressed predominantly in the stratum granulosum and stratum corneum, where it plays a central role in the proteolytic cascade governing desquamation — the regulated shedding of corneocytes from the skin surface. KLK5 activates other KLK family members, including KLK7 and KLK14, establishing it as an upstream regulator of a broader kallikrein protease network.
Dysregulation of KLK5 activity has been implicated in several skin pathologies. In Netherton syndrome, a rare genetic disorder caused by loss-of-function mutations in SPINK5 (encoding the serine protease inhibitor LEKTI), uncontrolled KLK5 activity leads to excessive desquamation, skin barrier defects, and atopic manifestations. KLK5 is also being investigated as a biomarker and potential therapeutic target in certain epithelial cancers.
Biochemical Properties and Recombinant Protein Considerations
Recombinant Human Kallikrein 5 Protein (SKU: rp368170) is produced using recombinant expression technology to deliver a well-characterized, research-grade serine protease for in vitro studies. The following biochemical considerations are important for experimental design:
- Protease Class: Serine protease; catalytic triad composed of His, Asp, and Ser residues, characteristic of the chymotrypsin superfamily.
- Substrate Specificity: Trypsin-like; cleaves after Arg and Lys residues. Synthetic fluorogenic substrates such as Boc-Val-Pro-Arg-AMC or Tos-Gly-Pro-Arg-pNA are commonly used for activity assays.
- Zymogen Activation: KLK5 is synthesized as an inactive zymogen (pro-KLK5) requiring proteolytic activation. Recombinant preparations may be supplied as the active enzyme or as the zymogen depending on the product format; consult the product datasheet for clarification.
- Inhibitors: Activity is inhibited by LEKTI domains, α2-macroglobulin, and classical serine protease inhibitors such as PMSF and aprotinin. Including appropriate inhibitor controls in assays is recommended.
- Glycosylation: KLK5 is a glycoprotein; glycosylation status may differ between expression systems (e.g., mammalian vs. bacterial), potentially affecting specific activity and folding.
Always verify activity and purity data provided in the Certificate of Analysis (CoA) before use, and perform a small-scale activity validation assay upon first use of a new lot.
Handling, Storage, and Reconstitution Protocol
Proper handling and storage of Recombinant Human Kallikrein 5 Protein are essential to maintain enzymatic activity and prevent degradation. Follow the guidelines below and always refer to the product-specific datasheet (rp368170) for lot-specific instructions.
Reconstitution
- Briefly centrifuge the vial before opening to consolidate lyophilized material.
- Reconstitute in sterile, ultrapure water or an appropriate buffer (e.g., 50 mM Tris-HCl, pH 8.0, 150 mM NaCl) to the recommended concentration as stated in the CoA.
- Allow the solution to sit for 5–10 minutes at room temperature with gentle swirling; avoid vigorous vortexing to prevent denaturation.
- Filter sterilize if required for cell-based assays.
Storage
- Store lyophilized protein at –20 °C or –80 °C, protected from moisture and light.
- Once reconstituted, aliquot into single-use volumes to avoid repeated freeze-thaw cycles, which can significantly reduce activity.
- Reconstituted protein should be stored at –80 °C for long-term storage or at 4 °C for short-term use (up to 1 week); add a carrier protein (e.g., 0.1% BSA) if storing dilute solutions.
Working Conditions
- Use low-binding tubes and pipette tips to minimize adsorption losses at low protein concentrations.
- Optimal assay conditions (pH, temperature, ionic strength, cofactors) should be validated empirically; consult the product datasheet for suggested starting conditions.
Research Applications
Recombinant Human Kallikrein 5 Protein is a versatile research reagent applicable across multiple scientific disciplines:
- Skin Biology and Desquamation Research: KLK5 is used to study the proteolytic events underpinning normal skin shedding and to model pathological conditions such as Netherton syndrome, Comel-Netherton syndrome variants, and atopic dermatitis where the KLK/LEKTI axis is disrupted.
- Protease Substrate Profiling: Used in degradomics and proteomic studies to identify and characterize KLK5 substrates in the extracellular matrix and on the cell surface, including corneodesmosin, desmoglein-1, and other structural proteins.
- Enzyme Kinetics and Inhibitor Screening: Suitable for determining kinetic parameters (Km, Vmax, kcat) and for high-throughput or medium-throughput screening of serine protease inhibitors as potential therapeutics.
- Kallikrein Cascade Studies: Enables dissection of the KLK activation cascade, particularly the role of KLK5 in activating KLK7 and KLK14, to understand feedforward protease amplification in skin.
- Cancer Biomarker Research: KLK5 is elevated in certain ovarian, breast, and other epithelial cancers; recombinant protein is used in ELISA development, antibody validation, and functional studies.
- Structural and Biophysical Studies: Used in crystallography, hydrogen-deuterium exchange mass spectrometry (HDX-MS), and other structural biology approaches to characterize the enzyme's active site and inhibitor-binding modes.
Quality Assurance and Ordering Information
Aladdin Scientific's Recombinant Human Kallikrein 5 Protein (SKU: rp368170) is manufactured and quality-controlled to meet the demands of rigorous research applications.
Quality Control
- Each lot is tested for purity (typically by SDS-PAGE and/or HPLC), identity (e.g., Western blot or mass spectrometry), and biological activity (enzyme activity assay).
- A Certificate of Analysis (CoA) is provided with each shipment and contains lot-specific data for all QC parameters.
- Endotoxin levels are measured and controlled; consult the CoA for lot-specific values, particularly important for cell-based assays.
Ordering
- SKU: rp368170
- Product Name: Recombinant Human Kallikrein 5 Protein
- Contact Aladdin Scientific customer service or visit the product page for current pricing, available quantities, and lead times.
- Bulk quantities and custom formulations may be available upon request.
Shipping and Storage on Receipt
- The protein is typically shipped on dry ice; inspect the package upon receipt and confirm that the product remains frozen or in the appropriate physical state.
- Transfer immediately to –80 °C storage upon receipt unless immediate use is planned.
Frequently asked questions
What is Recombinant Human Kallikrein 5 Protein used for in research?
Recombinant Human Kallikrein 5 Protein is primarily used to study epidermal desquamation, skin barrier dysfunction, and the kallikrein protease cascade. It is also applied in enzyme kinetics assays, serine protease inhibitor screening, cancer biomarker studies, and substrate identification via proteomics approaches.
How should I store and handle Recombinant Human Kallikrein 5 Protein to preserve activity?
Lyophilized protein should be stored at –20 °C or –80 °C protected from moisture. After reconstitution, aliquot immediately into single-use volumes and store at –80 °C for long-term use or at 4 °C for short-term use (up to one week). Avoid repeated freeze-thaw cycles, use low-binding labware, and add a carrier protein such as 0.1% BSA when preparing dilute solutions.
What buffer is recommended for reconstituting Recombinant Human Kallikrein 5 Protein?
Sterile ultrapure water or a mild physiological buffer such as 50 mM Tris-HCl (pH 8.0) with 150 mM NaCl is generally suitable for reconstitution. Always consult the lot-specific Certificate of Analysis (CoA) provided with product rp368170 for the recommended reconstitution buffer and volume.
Is Kallikrein 5 relevant to any human diseases?
Yes. KLK5 dysregulation is closely linked to Netherton syndrome, a rare hereditary skin disorder caused by loss-of-function mutations in SPINK5, resulting in uncontrolled KLK5 proteolytic activity and severe skin barrier defects. KLK5 is also implicated in atopic dermatitis pathophysiology and has been investigated as a biomarker in certain epithelial cancers including ovarian and breast cancer.
How can I confirm that my recombinant KLK5 preparation is enzymatically active?
Enzymatic activity can be confirmed using a fluorogenic or chromogenic substrate assay specific for trypsin-like serine proteases, such as substrates containing Arg-AMC or pNA-coupled peptides. Measure fluorescence or absorbance over time in the presence and absence of a serine protease inhibitor (e.g., PMSF or aprotinin) to confirm specific activity. Refer to the CoA for the lot-specific activity value provided by Aladdin Scientific.
References
- Lundwall A, Brattsand M. Kallikrein-related peptidases. Cell Mol Life Sci. 2008;65(13):2019-2038. doi:10.1007/s00018-008-8024-3
- Hovnanian A. Netherton syndrome: skin inflammation and allergy by loss of protease inhibition. Cell Tissue Res. 2013;351(2):289-300. doi:10.1007/s00441-013-1558-0
- Egelrud T, Brattsand M, Kreutzmann P, et al. hK5 and hK7, two serine proteinases abundant in human skin, are inhibited by LEKTI domain 6. Br J Dermatol. 2005;153(6):1200-1203.
- Borgoño CA, Diamandis EP. The emerging roles of human tissue kallikreins in cancer. Nat Rev Cancer. 2004;4(11):876-890. doi:10.1038/nrc1474
Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.
危险品化学品经营许可证(带存储)